Hims & Hers Stock Drops After Q1 Loss and Weak Earnings Guidance
Telehealth company Hims & Hers saw its stock fall nearly 16% in premarket trading after reporting a $92 million net loss for the first quarter, an increase from $50 million last year. The firm also issued weaker-than-expected earnings guidance and announced plans to transition away from compounded GLP-1 drugs.
Topics: loss_expansion q1_earnings stock_drop weight_loss_drugs